Protagonist Therapeutics, Inc. (PTGX)
NASDAQ: PTGX · Real-Time Price · USD
92.09
+0.68 (0.74%)
At close: Mar 6, 2026, 4:00 PM EST
95.88
+3.79 (4.12%)
After-hours: Mar 6, 2026, 6:00 PM EST
Protagonist Therapeutics Analyst Ratings
Total Analysts
12
Consensus Rating
Strong Buy
Price Target
$100.17
Upside
+8.77%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Hold Maintains $65 → $95 | Hold | Maintains | $65 → $95 | +3.16% | Mar 3, 2026 |
| TD Cowen | TD Cowen | Strong Buy Maintains $90 → $100 | Strong Buy | Maintains | $90 → $100 | +8.59% | Feb 26, 2026 |
| Barclays | Barclays | Buy Maintains $108 → $113 | Buy | Maintains | $108 → $113 | +22.71% | Feb 26, 2026 |
| Citizens | Citizens | Buy Maintains $102 → $112 | Buy | Maintains | $102 → $112 | +21.62% | Feb 26, 2026 |
| Jefferies | Jefferies | Strong Buy Maintains $95 → $118 | Strong Buy | Maintains | $95 → $118 | +28.14% | Feb 2, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $80 → $117 | Strong Buy | Maintains | $80 → $117 | +27.05% | Jan 30, 2026 |
| Truist Securities | Truist Securities | Strong Buy Maintains $88 → $110 | Strong Buy | Maintains | $88 → $110 | +19.45% | Jan 5, 2026 |
| Barclays | Barclays | Buy Maintains $88 → $108 | Buy | Maintains | $88 → $108 | +17.28% | Dec 17, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $98 → $115 | Strong Buy | Maintains | $98 → $115 | +24.88% | Dec 8, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $96 → $98 | Strong Buy | Maintains | $96 → $98 | +6.42% | Nov 10, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $68 → $81 | Buy | Maintains | $68 → $81 | -12.04% | Nov 7, 2025 |
| Barclays | Barclays | Buy Maintains $72 → $88 | Buy | Maintains | $72 → $88 | -4.44% | Nov 7, 2025 |
| Citizens | Citizens | Buy Maintains $69 → $102 | Buy | Maintains | $69 → $102 | +10.76% | Nov 7, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $76 → $88 | Strong Buy | Maintains | $76 → $88 | -4.44% | Oct 28, 2025 |
| Wedbush | Wedbush | Buy Maintains $70 → $86 | Buy | Maintains | $70 → $86 | -6.61% | Oct 28, 2025 |
| BTIG | BTIG | Strong Buy Reiterates $82 | Strong Buy | Reiterates | $82 | -10.96% | Oct 28, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.